American Trust Novo Nordisk A S Transaction History

American Trust

$370 Million
Q1 2025

A detailed history of American Trust transactions in Novo Nordisk A S stock. As of the latest transaction made, American Trust holds 5,365 shares of NVO stock, worth $363,210. This represents 0.1% of its overall portfolio holdings.

Number of Shares

5,365

Previous 13,589 60.52%

Holding current value

$363,210

Previous $1.17 Million 68.15%

% of portfolio

0.1%

Previous 0.1%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 16, 2025	SELL	$69.3 - $90.95 $569,923 - $747,972	-8,224 Reduced 60.52%	5,365 $372,000
Q4 2024 Feb 18, 2025	BUY	$85.0 - $120.04 $73,440 - $103,714	864 Added 6.79%	13,589 $1.17 Million
Q3 2024 Nov 29, 2024	BUY	$119.07 - $145.42 $881,356 - $1.08 Million	7,402 Added 139.06%	12,725 $1.52 Million
Q2 2024 Sep 11, 2024	SELL	$122.71 - $146.91 $3,313 - $3,966	-27 Reduced 0.5%	5,323 $759,000
Q1 2024 Jun 11, 2024	SELL	$102.11 - $135.92 $80,258 - $106,833	-786 Reduced 12.81%	5,350 $686,000
Q4 2023 Feb 21, 2024	BUY	$87.78 - $105.45 $10,709 - $12,864	122 Added 2.03%	6,136 $634,000
Q3 2023 Nov 15, 2023	BUY	$90.94 - $199.54 $228,895 - $502,242	2,517 Added 71.98%	6,014 $546,000
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $15,597 - $17,265	-100 Reduced 2.78%	3,497 $565,000
Q1 2023 May 22, 2023	SELL	$132.34 - $159.14 $49,627 - $59,677	-375 Reduced 9.44%	3,597 $572,000
Q4 2022 Feb 16, 2023	SELL	$102.55 - $135.33 $36,918 - $48,718	-360 Reduced 8.31%	3,972 $537,000
Q3 2022 Dec 02, 2022	SELL	$95.28 - $116.93 $19,056 - $23,386	-200 Reduced 4.41%	4,332 $432,000
Q2 2022 Oct 03, 2022	BUY	$103.24 - $121.81 $82,592 - $97,448	800 Added 21.44%	4,532 $505,000
Q1 2022 Jun 08, 2022	BUY	$93.1 - $112.54 $347,449 - $419,999	3,732 New	3,732 $414,000

Others Institutions Holding NVO

# of Institutions

1,769

Shares Held

330M

Call Options Held

11.3M

Put Options Held

15.5M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $153B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Trust, based on Form 13F filings with the SEC.

News

Stay updated on American Trust with notifications on news.

Account